Print

Print


Keeping Parkinson's Disease In Check ... DBS Surgery
From:ireland.com
Monday, 8th December, 2003

A radical treatment could halt the condition in at least some of the people suffering from it, writes Dick Ahlstrom,
Science Editor.

It is the simplest aspects of life that seem most precious when a disease takes them away. So it was for a long-term
Parkinson's disease patient who almost magically had his life restored after receiving a radical new treatment. When Dr
Brendan Colgan, from Rathfarnham in Dublin, travelled to France three months ago, he was ferried into surgery in a
wheelchair. After treatment he was able to walk back to his hospital bed, eat lunch, then enjoy a long walk with his
wife, another simple pleasure Colgan feared he had lost. "I can bring my children to school now, participate in their
birthdays and help them with their homework," he says. "I always liked to cook Sunday dinner, peeling spuds, small
simple things, doing the garden. It is a whole new world out there."

Colgan's surgery, known as deep brain stimulation, was carried out by the medical research group in Grenoble that
developed the treatment. It involves inserting metal probes deep into the brain to pass a weak electric current through
tissues associated with Parkinson's disease. Pulses of electricity block the aberrant messages from the brain that
cause a range of symptoms, including tremors and muscle stiffness.

Colgan couldn't have the surgery here, as it isn't available. This may soon change, however, as a result of an
application for funding that Beaumont Hospital in Dublin intends to make to the Department of Health and Children.
"Beaumont has looked at the new treatment and is interested in introducing it," says a hospital spokesman. Beaumont
already has much of the equipment for the procedure, but it lacks the money to train a surgeon, buy the probe-
positioning software or install the stimulation device in patients.

The cost of treating someone with Parkinson's using the deep brain stimulation system is likely to be about €30,000 a
patient - surprisingly, much cheaper than the medication required by many people with Parkinson's. Colgan's drug costs
had reached €161,000 a year before his surgery. The deep brain stimulation, including travel, cost about €40,000, and
now he only occasionally needs to take medication, so the treatment will have paid for itself in three months.

These are only numbers, however, when compared with the change in his quality of life. "My voice was about gone to
nothing and I had all the classical features of severe Parkinson's. My quality of life was desperate and my family's
quality of life was desperate," he says.

"I was taking very high doses of apomorphine [an anti-Parkinson's drug\] every one to two hours," as well as levodopa
and other drugs, says Colgan. "The dose requirement was increasing, but the control of symptoms was decreasing. For the
last two to three years I was going rapidly downhill."

His first symptom, unexplained tiredness, arrived more than 10 years ago, but the diagnosis when it eventually came was
a shock. As a doctor he knew the disease usually didn't arise until a person passed 60, but he was only in his 40s,
with three young children (now 16, 13 and 12). He also knew the uncompromisingly negative long-term prognosis for the
disease.

He was aware of a number of surgical procedures involving the destruction of brain cells, but while he was considering
what to do, "deep brain stimulation was coming into the picture", says Colgan.

"It was last December that Donal Costigan [his doctor at Mater Misericordiae University Hospital, in Dublin\] discussed
the pros and cons of going for it. Donal said I was in such rag order he suggested I go for it."

Colgan travelled to Grenoble in March for an initial assessment, a doctor's visit that cost just €34. Having been found
to be a highly suitable candidate, he was admitted for surgery on September 11th last year, with the operation coming
on September 23rd.

It was done under local anaesthetic - brain tissue has no pain sensors - and lasted 29 hours.

It took that long because Pierre Pollak, the neurologist involved, likes to chat with his patients as he fine-tunes the
probes. He varies the electricity levels, checking with the patient to gauge the physical response and the benefit
delivered. It allows him to "dial up" limb movement, reduce tremors and return normal speech - as well as to avoid
producing any new symptoms.

"It was the longest day of my life but the best day of my life," Colgan says. He describes his condition now as
"magnificent", and as he walks around Dublin he surprises many friends who had got used to seeing him in a wheelchair.
He quotes his local priest, who said: "I never thought I would see a miracle walk in."

Deep brain stimulation can transform the lives of some people with Parkinson's disease, but Colgan warns that many
others are unsuitable candidates for the treatment.

"There are probably 7,000 to 8,000 Parkinson's patients here," he says. "I think that there are probably 100 to 300
patients who could benefit from this per year."

Colgan is now back to work part time as a GP. He also plans to make up for lost walking time with an ambitious fund-
raising attack on the highest mountain in the Alps, something he promised both to himself and to Pollak.

"I promised I would climb Mont Blanc, and I hope to undertake that next summer," he says. "I will be fit enough to do
it - and the proceeds will go to the Parkinson's Association of Ireland."Deep brain stimulation is a radical treatment
for Parkinson's disease developed 10 years ago by a medical research group in the French city of Grenoble. Approved by
the powerful US Food and Drug Administration only about two years ago, it can profoundly reduce tremors and other
symptoms more cheaply than drug therapy.

Parkinson's is an incurable progressive disease in which patients gradually lose control of their movement. Muscles
become stiff and severe tremors are common, with a slow but relentless loss of quality of life. Up to 7,000 people in
the Republic have the condition. Elsewhere, well-known sufferers include the Pope, Muhammad Ali and Michael J. Fox.

The disease arises due to the loss of brain cells that produce an essential brain-signalling chemical called dopamine.
The "gold standard" treatment uses levodopa, a drug that replaces missing dopamine, but long-term use can produce side
effects.

Parkinson's physical symptoms are thought to arise due to the overactivity of a tiny part of the brain called the
subthalamic nucleus, just below the thalamus. The research group found that electrical stimulation of the subthalamic
nucleus blocked its over- activity, causing symptoms to subside.

The new treatment involves inserting two metal probes deep into the brain, each of which carries four separate
electrodes. These are connected to a power pack that can be implanted under the skin. The electrodes deliver pulses of
very low-power electricity, blocking disruptive signals from the subthalamic nucleus.

A five-year follow-up published last month in the New England Journal of Medicine concluded that it delivered "marked
improvements" to motor function without medication.

SOURCE: Irish Times / eircom net
http://home.eircom.net/content/irelandcom/topstories/2110810?view=Eircomnet

* * *

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn